DELETE Diagnosis, Medication Selection, and Dosing for Specific Indications

Recently published article about DELETE Diagnosis, Medication Selection, and Dosing for Specific Indications

JCP
DELETE Diagnosis, Medication Selection, and Dosing for Specific Indications

January 1, 2004

JCP
DELETE Diagnosis, Medication Selection, and Dosing for Specific Indications

January 1, 2004

JCP
DELETE Diagnosis, Medication Selection, and Dosing for Specific Indications

January 1, 2004

JCP
DELETE Diagnosis, Medication Selection, and Dosing for Specific Indications

January 1, 2004

JCP
DELETE Diagnosis, Medication Selection, and Dosing for Specific Indications

January 1, 2004

JCP
DELETE Diagnosis, Medication Selection, and Dosing for Specific Indications

January 1, 2004

Recent JCP Articles on DELETE Diagnosis, Medication Selection, and Dosing for Specific Indications

JCP
Case Report

August 26, 2024

A man with AUD achieves sobriety on treatment with an SSRI and naltrexone, but then stops taking the SSRI to participate in a psilocybin “ceremony.” What factors contributed to...
Mark A. Frye, Balwinder Singh, Scott A. Breitinger, et al
JCP
Commentary

August 26, 2024

Dr Freeman discusses a recent study by Pacilio et al that characterized real world practices around ketamine treatment and pregnancy testing, consent processes, and contraception use. She emphasizes the...
Marlene P. Freeman
JCP
Olanzapine and Mirtazapine for Cancer-Related Anorexia
Clinical and Practical Psychopharmacology

August 21, 2024

Dr Andrade discusses two RCTs that investigated the utility of olanzapine and mirtazapine in addressing appetite loss in cancer patients.
Chittaranjan Andrade

Recent PCC Articles on DELETE Diagnosis, Medication Selection, and Dosing for Specific Indications

PCC
Panic Attacks Masquerading as Intractable Vomiting
Case Report

August 22, 2024

The authors present a perplexing and atypical manifestation of panic attacks presenting as intractable vomiting in a young patient.
Ajzal A. Zain, Tanvi Mittal, Nishanth Jalaja Haridas
PCC
Smartphone Applications: Therapy at Your Fingertips
Letter to the Editor

August 20, 2024

The authors discuss the advancements in smartphone applications for psychiatry, as well as some of the risks.
Vania Modesto-Lowe, Sofia Adams, Amanda Rossi
PCC
Zeroing in on Xylazine
Letter to the Editor

August 15, 2024

The authors discuss the need to raise awareness among US public and health care professionals about xylazine due to its infiltration into the illicit drug supply.
Jasleen Kaur, Megan Nosol, Vania Modesto-Lowe

Featured DELETE Diagnosis, Medication Selection, and Dosing for Specific Indications Research

JCP
Economic Impact of Cognitive Impairment and Negative Symptoms in Schizophrenia
Review Article

August 21, 2024

Patients with schizophrenia and cognitive impairment had a 100% increase in relapse-related hospitalizations and ER visits versus patients with no (or only mild) cognitive impairment.
Christoph U. Correll, Pin Xiang, Kaushik Sarikonda, et al
JCP
Functional Unblinding in Pivotal Studies and the Future of Psychedelic Medicine
Commentary

August 21, 2024

Dr Rosenbaum comments on the challenge of evaluating trials of treatments whose effects are unmistakable, and how this dilemma may be addressed.
Jerrold F. Rosenbaum
JCP
Adjunctive Treatment Targeting Multiple Mechanisms in Schizophrenia
Narrative Review

August 19, 2024

While the pathophysiology of schizophrenia is complex, treatments with novel pharmacological actions that target these systems are of interest as adjunctive treatment for schizophrenia.
Bruce J. Kinon, Stefan Leucht, Carol Tamminga, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe